108 related articles for article (PubMed ID: 13512101)
1. [Clinical contribution to the evaluation of cardiac efficiency by esbericard].
ACKERMANN J
Dtsch Med J; 1958 Feb; 9(2):68-70. PubMed ID: 13512101
[No Abstract] [Full Text] [Related]
2. [Therapeutic use of crataegus, a result of modern botanic pharmacology].
MEYER E
Munch Med Wochenschr; 1952 Jun; 94(24):1225-8. PubMed ID: 12982796
[No Abstract] [Full Text] [Related]
3. [Therapy with Cor-Vel liquid in pre-digitalization].
Chirstl G
Z Allgemeinmed; 1973 Jul; 49(19):938-9. PubMed ID: 4737972
[No Abstract] [Full Text] [Related]
4. [Percutaneous treatment of the so-called anginal disorders].
Mahr H
Z Allgemeinmed; 1974 Jan; 50(1):37-40. PubMed ID: 4814872
[No Abstract] [Full Text] [Related]
5. [Prolonged digitalization without digitalis poisoning].
Kührt D
Ther Ggw; 1967 Sep; 106(9):1194 passim. PubMed ID: 5630221
[No Abstract] [Full Text] [Related]
6. [Clinical experiences in the treatment of heart insufficiency with miroton].
JANKE B
Medizinische; 1955 Jun; 23():852-3. PubMed ID: 13244146
[No Abstract] [Full Text] [Related]
7. [Indications for Crataegus therapy].
STORCH H
Med Klin; 1954 Aug; 49(34):1331-4. PubMed ID: 13203011
[No Abstract] [Full Text] [Related]
8. [Spring adonis (Adonis vernalis L.)].
Sorokina AA
Med Sestra; 1989 Sep; 48(9):43-5. PubMed ID: 2593790
[No Abstract] [Full Text] [Related]
9. Contribution of clinical pharmacology to a rational use of cardiac glycosides in Czechoslovakia.
Sechser T; Petrásek R; Stika L; Modr Z; Elis J; Malý J
Pol J Pharmacol Pharm; 1989; 41(6):527-32. PubMed ID: 2485902
[TBL] [Abstract][Full Text] [Related]
10. [Practical experiences with miroton in therapy of cardiovascular diseases].
STOHR W
Hippokrates; 1952 Dec; 23(23):676-8. PubMed ID: 13034159
[No Abstract] [Full Text] [Related]
11. [Experience in the use of the new Soviet preparation Amorphin (Fruticin) for the prevention of attacks of paroxysmal tachycardia].
Moiseev SG; Ustinova EZ
Sov Med; 1967 Dec; 30(12):53-6. PubMed ID: 5606293
[No Abstract] [Full Text] [Related]
12. [Therapeutic observations on the orally effective cardiac glycosides of Erysimum canescens Roth].
Meixner HK
Med Welt; 1969 Apr; 17():1034-6. PubMed ID: 5784740
[No Abstract] [Full Text] [Related]
13. [Ouabain: from an arrow poison to a new steroidal hormone].
Mucaji P; Nagy M; Grancai D
Ceska Slov Farm; 2005 Sep; 54(5):207-10. PubMed ID: 16209434
[TBL] [Abstract][Full Text] [Related]
14. [Non-specific pharmacodynamic studies of pure extract of Helleborus species (hellecard)].
SIMIONESCU-CARAPANCEA S
Bul Stiint Sect Stiint Medicale Acad Republicii Pop Romane; 1956; 8(4):907-18. PubMed ID: 13500000
[No Abstract] [Full Text] [Related]
15. The therapeutic value of the cardiac glycosides.
BAYLIS JH
Br J Clin Pract; 1959 Jan; 13(1):34-7 passim. PubMed ID: 13618486
[No Abstract] [Full Text] [Related]
16. [Preventive administration of cardiac glycosides].
Haslbeck M
Munch Med Wochenschr; 1971 Dec; 113(51):1722-3. PubMed ID: 5172167
[No Abstract] [Full Text] [Related]
17. [Treatment of cervical migraine with Venopyronum].
Rahm E
Munch Med Wochenschr; 1972 May; 114(20):992-4. PubMed ID: 4677703
[No Abstract] [Full Text] [Related]
18. [Practical use of cardiac glycosides].
Ignat'ev MV
Voen Med Zh; 1976 Sep; (9):78-80. PubMed ID: 1034366
[No Abstract] [Full Text] [Related]
19. [Biochemical aspects of the therapeutic use of cardiac glycosides].
Savitskiĭ NN
Ter Arkh; 1972 Jan; 44(1):5-11. PubMed ID: 5017540
[No Abstract] [Full Text] [Related]
20. [The glycosides of the leaves from Isoplexis isabelliana (Webb) Masf].
Freitag H; Spengel S; Linde HH; Meyer K
Helv Chim Acta; 1967 Jul; 50(5):1336-66. PubMed ID: 5600940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
